16th Edition Strategic Partnerships & Portfolio Optimization for Accessible Medicines, Specialty Therapeutics, and Generic Drugs Conference

Maximizing Alliances, Decision Making, and Licensing through Analysis of Data, Deals, and Leadership

Event Date: September 18-19, 2024

Location: The Westin New Orleans, New Orleans, LA

Morristown, NJ – June 5, 2024 – marcus evans proudly announces the 16th Edition of the Strategic Partnerships & Portfolio Optimization for Accessible Medicines, Specialty Therapeutics, and Generic Drugs conference. This premier event will take place on September 18-19, 2024, in Morristown, NJ, and is a must-attend for industry leaders aiming to innovate business models, optimize portfolios, and drive successful alliances.

Conference Overview:

To sustain a competitive advantage, manufacturers of generic drugs, biologics, biosimilars, and non-branded drugs need to innovate their business models, deal structures, and organizations. This conference will provide attendees with the opportunity to review successful alliances, partnerships, M&A activities, and portfolio strategies at the right size, price, and mix of complexity to sustain value optimization in both domestic and international markets.

Key Themes:

• Successful Alliances and Innovation: Learn from case studies of successful partnerships and innovative strategies in the pharmaceutical industry.
• Strategic Portfolio Management: Understand how to balance portfolios with the optimal mix of internal and external capabilities.
• Navigating Regulatory Landscapes: Gain insights into the impacts of recent legislation and regulatory changes, such as the Inflation Reduction Act, on the industry.

Keynote Speakers and Industry Experts:

• Stephen Beckman, CEO, Yaral Pharma
• Nicole L. Duff DeSantis, Founder / Principal, PuzzlePharm
• Dinakaran Balasubramanian, Head of Commercial Strategy & Analytics, Biologics, Dr. Reddy's Laboratories
• Amit Kumar, Head of Corporate PMO, American Regent (Daiichi Sankyo Company)
• Sandeep Kumar, Director, Product Development, R&D, SUN PHARMA
• Malcolm Rosenthal, Sr. Director Business Development, Escientia Life Sciences
• Nikhila Shashikanth, Director Business Development & Operations, Spring Bio Solutions, USA
• Mahendra Gunjal, Senior Manager, Portfolio Management, Azurity Pharmaceuticals

Conference Agenda Highlights:

• Keynote Address by Stephen Beckman on "Path to Success for Accessible Medicines and Portfolio Diversification."
• Panel Discussions on optimizing relationships with CDMOs and CMOs, understanding market risks and opportunities, and the future of generic drugs.
• Fireside Chat on strategy and portfolio optimization in the context of policy and pricing constraints.
• In-depth Sessions on the impacts of the Inflation Reduction Act, Generic Drug User Fee Amendments (GFUDA), and other regulatory frameworks.

About marcus evans: marcus evans is a leading provider of strategic conferences, summits, and professional training. For over 30 years, marcus evans has delivered innovative and timely events that provide senior executives with cutting-edge information and networking opportunities.

Media Contact: Ayis Panayi, Senior Digital Marketing & PR Executive, ayisp@marcusevanscy.com 

For more information and to register for the conference, visit: https://bit.ly/4e8YHcn